The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Prostaglandins, Arachidonic Acid, and Inflammation
Abstract
The enzymatic oxidation of arachidonic acid has been shown to yield potent pathological agents by two major pathways. Those of the prostaglandin (PG) pathway, particularly PGE 2, have been implicated as inflammatory mediators for many years. The discovery and biological activities of thromboxane A 2 and prostacyclin as well as a destructive oxygen-centered radical as additional products of this biosynthetic pathway now require these to be considered as potential inflammatory mediators. Like PGE 2, their biosynthesis is prevented by nonsteroidal anti-inflammatory agents. More recently, the alternative metabolic route, the lipoxygenase pathway, has been shown to yield a new class of arachidonic acid oxygenation products, called the leukotrienes, which also appear to be important inflammatory mediators. Unlike the prostaglandins, some of which play important roles as biological regulators, the actions of the lipoxygenase products appear to be exclusively of a pathological nature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hamberg, M., Svensson, J., & Samuelsson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
Babior, B. M., Kipnes, R. S., & Curnutte, J. T. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107236 · Cited by 2,931
Ford-Hutchinson, A. W., Bray, M. A., Doig, M. V., Shipley, M. E., & Smith, M. J. H. (1980) · Nature · doi:10.1038/286264a0 · Cited by 2,060
Fridovich, I. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.001051 · Cited by 1,730
Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
Moncada, S., & Vane, J. R. (1978) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06759-6 · Cited by 1,576
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets
Hamberg, M., & Samuelsson, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.9.3400 · Cited by 1,407
The Biochemical Basis of Phagocytosis
Sbarra, A. J., & Karnovsky, M. L. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70011-2 · Cited by 1,251
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
Murphy, R. C., Hammarström, S., & Samuelsson, B. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4275 · Cited by 991
FLOWER, R. J., & BLACKWELL, G. J. (1979) · Nature · doi:10.1038/278456a0 · Cited by 917
Superoxide‐dependent production of hydroxyl radical catalyzed by iron—EDTA complex
McCord, J. M., & Day, E. D. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80116-1 · Cited by 868
Isolation and properties of intermediates in prostaglandin biosynthesis
Nugteren, D. H., & Hazelhof, E. (1973) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(73)90145-8 · Cited by 789
Production of diglyceride from phosphatidylinositol in activated human platelets.
Rittenhouse-Simmons, S. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109339 · Cited by 723
Diglyceride lipase: a pathway for arachidonate release from human platelets.
Bell, R. L., Kennerly, D. A., Stanford, N., & Majerus, P. W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3238 · Cited by 687
The importance of phospholipase-A2 in prostaglandin biosynthesis
Flower, R. J., & Blackwell, G. J. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90216-1 · Cited by 642
Detection and Isolation of an Endoperoxide Intermediate in Prostaglandin Biosynthesis
Hamberg, M., & Samuelsson, B. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.899 · Cited by 641
Petrone, W. F., English, D. K., Wong, K., & McCord, J. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.1159 · Cited by 616
Arachidonate lipoxygenase in blood platelets
Nugteren, D. H. (1975) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(75)90016-8 · Cited by 613
Zurier, R. B., Weissmann, G., Hoffstein, S. T., Kammerman, S., & Tai, H. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107550 · Cited by 588
Mechanism for irreversible self-deactivation of prostaglandin synthetase.
Egan, R. W., Paxton, J., & Kuehl, F. A. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32853-3 · Cited by 586
Self-citationMacrophages synthesise and release prostaglandins in response to inflammatory stimuli
HUMES, J. L., BONNEY, R. J., PELUS, L., DAHLGREN, M. E., SADOWSKI, S. J., KUEHL, F. A., & DAVIES, P. (1977) · Nature · doi:10.1038/269149a0 · Cited by 571
Self-citationBorgeat, P., & Samuelsson, B. O. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)36026-5 · Cited by 550
Samuelsson, B., Granstrom, E., Green, K., Hamberg, M., & Hammarstrom, S. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.003321 · Cited by 529
A new approach to anti-inflammatory drugs
Higgs, G. A., Flower, R. J., & Vane, J. R. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90651-8 · Cited by 501
Winter, C. A., Risley, E. A., & Nuss, G. W. (1963) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26625-3 · Cited by 418
Smith, W. L., & Lands, W. E. M. (1972) · Biochemistry · doi:10.1021/bi00767a024 · Cited by 357
Prostaglandin biosynthesis can be triggered by lipid peroxides
Hemler, M. E., Cook, H. W., & Lands, W. E. M. (1979) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(79)90038-9 · Cited by 351
PROSTAGLANDIN E2, PROSTAGLANDIN I2 AND THE VASCULAR CHANGES OF INFLAMMATION
WILLIAMS, T. J. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb07860.x · Cited by 344
Gryglewski, R. J., Panczenko, B., Korbut, R., Grodzińska, L., & Ocetkiewicz, A. (1975) · Prostaglandins · doi:10.1016/s0090-6980(75)80087-6 · Cited by 336
Structure of leukotriene C identification of the amino acid part
Hammarström, S., Murphy, R. C., Samuelsson, B., Clark, D. A., Mioskowski, C., & Corey, E. J. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91203-8 · Cited by 305
I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process
Ferreira, S. H., & Nakamura, M. (1979) · Prostaglandins · doi:10.1016/0090-6980(79)90103-5 · Cited by 283
Dayer, J. M., Bréard, J., Chess, L., & Krane, S. M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109596 · Cited by 281
Inhibition of prostaglandin synthesis in man
Hámberg, M. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90470-6 · Cited by 276
Prostaglandin Synthetase Inhibitors I
Shen, T. Y. (1979) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-66891-3_12 · Cited by 274
Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils.
Goetzl, E. J., & Sun, F. F. (1979) · The Journal of experimental medicine · doi:10.1084/jem.150.2.406 · Cited by 260
Gryglewski, R. J., Panczenko, B., Korbut, R., Grodzińska, L., & Ocetkiewicz, A. (1975) · Prostaglandins · doi:10.1016/0090-6980(75)90053-2 · Cited by 241
Peroxidase-dependent deactivation of prostacyclin synthetase
Ham, E. A., Egan, R. W., Soderman, D. D., Gale, P. H., & Kuehl, F. A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30204-1 · Cited by 230
Self-citationTomlinson, R. V., Ringold, H. J., Qureshi, M. C., & Forchielli, E. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80174-8 · Cited by 218
Co-oxygenation of organic substrates by the prostaglandin synthetase of sheep vesicular gland.
Marnett, L., Wlodawer, P., & Samuelsson, B. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40789-8 · Cited by 207
PROSTAGLANDIN E1: A POTENTIAL MEDIATOR OF THE INFLAMMATORY RESPONSE
Kaley, G., & Weiner, R. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb53203.x · Cited by 198
Reduction of hydroperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase.
Egan, R. W., Gale, P. H., & Kuehl, F. A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50758-4 · Cited by 159
Self-citationParticipation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema
Ōyanagui, Y. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90062-9 · Cited by 151
Direct Evidence for a Prostaglandin Receptor and Its Application to Prostaglandin Measurements
Kuehl, F. A., & Humes, J. L. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.2.480 · Cited by 125
Self-citationGoetzl, E. J., Hill, H. R., & Gorman, R. R. (1980) · Prostaglandins · doi:10.1016/0090-6980(80)90155-0 · Cited by 111
Cyclo-oxygenase products in carrageenin-induced inflammation
Higgs, G. A., & Salmon, J. A. (1979) · Prostaglandins · doi:10.1016/s0090-6980(79)80045-3 · Cited by 109
Accelerative autoactivation of prostaglandin biosynthesis by PGG2
Hemler, M. E., Graff, G., & Lands, W. E. M. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91148-8 · Cited by 99
Gabig, T. G., Kipnes, R. S., & BABIOR, B. M. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37968-1 · Cited by 90
Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue
Gräf, P., Glatt, M., & Brune, K. (1975) · Cellular and Molecular Life Sciences · doi:10.1007/bf02358871 · Cited by 71
Safety tests of orgotein, an antiinflammatory protein
Carson, S., Vogin, E. E., Huber, W., & Schulte, T. L. (1973) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(73)90252-4 · Cited by 51
Edsmyr, F., Huber, W., & Menander-Huber, K. B. (1976) · PubMed · Cited by 49
Hydrocortisone inhibition of the bradykinin activation of human synovial fibroblasts
Newcombe, D. S., Fahey, J. V., & Ishikawa, Y. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90005-3 · Cited by 47
Hassid, A., & Levine, L. (1977) · PubMed · Cited by 45
Hammarström, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86204-x · Cited by 31
LINDGREN, J. Å., Claesson, H., & Hammarström, S. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90136-8 · Cited by 29
Cited by
Ischemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043
The biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
Kohen, R., & Nyska, A. (2002) · Toxicologic Pathology · doi:10.1080/01926230290166724 · Cited by 2,178
Lipid peroxidation and antioxidants as biomarkers of tissue damage
Gutteridge, J. M. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.12.1819 · Cited by 1,844
Role of ROS and RNS Sources in Physiological and Pathological Conditions
Di Meo, S., Reed, T. T., Venditti, P., & Victor, V. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1245049 · Cited by 1,614
Metadata
- Authors
- Kuehl, F. A., & Egan, R. W.
- Venue
- Science
- Published
- 1980-11-28
- Volume
- 210
- Issue
- 4473
- Pages
- 978-984
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2034323095
- Cited by
- 708
- References
- 57
- FWCI
- 38.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.